В июне 2022 г. состоялось заседание Совета экспертов, посвященное возможностям
применения ингибитора рецептора интерлейкина (ИЛ) 1 анакинры для терапии …

In early 2020, a global pandemic was announced due to the emergence of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), known to cause COVID-19. Despite …

Aim: Aim of this study was to evaluate the effect of anakinra (ANK) addition to remdesivir
(RDV) on all-cause 28-day mortality in patients hospitalized with COVID-19. Patients & …

The COVID-19 pandemic had a profound impact on global health, economies, and social
systems. The crucial factor that determines the success of COVID-19 treatments is …

OBJECTIVE: This study estimated delirium incidence in Slovak COVID-19 patients, explored
treatment associations and examined the impact on hospitalization and mortality …

The maneuver clinical investigation of an effective drug for coronavirus disease 2019
(COVID-19) is still ongoing and the milieu of a successful investigational drug with proven …

Coronavirus disease (COVID‐19) is an emergency pandemic with a high mortality rate
worldwide. One of its complications in children is developing multisystemic inflammatory …

Objective: This study aimed to determine whether the medication alone might be effective in
the drug-induced liver damage that was reported during coronavirus disease-2019 (COVID …

Infectious diseases are a major global health issue, particularly at a time when resistance to
antibiotics is increasing. Viewing infections as a consequence of immune system …

Amaç: İkinci ve üçüncü basamak hastanelerin Koronavirüs (COVID) servislerinde çalışan
hekimlerin 2 yıl içinde sağaltım seçeneklerine bakışlarındaki değişiklikleri belirlemektir …